ProUroCare Medical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PUMD research report →
Price Chart
About the company
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution.
- CEO
- Benjamin Banks
- IPO
- 2022
- Employees
- 2
- HQ
- Eden Prairie, MN, US
Get TickerSpark's AI analysis on PUMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.86K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.45
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 90.34%
- ROIC
- 78.69%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,982,086
- Net Income
- $-2,959,145-43.4%
- EPS
- $-0.17-30.8%
- OCF Growth
- -33.8%
- FCF Growth
- -34.9%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.31
- RSI (14)
- 0
- Avg Volume
- 553
No earnings-call transcripts are available for PUMD yet.
- Free Float
- 77.3%
- Shares Outstanding
- 18.60M
- Float Shares
- 14.37M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 31, 14 | Shuler Alan | other | 23,987 |
| Jan 15, 14 | Reiling William | buy | 75,000 |
| Jan 15, 14 | Reiling William | buy | 0 |
| Jan 15, 14 | DAVIS JAMES L | buy | 75,000 |
| Jan 15, 14 | DAVIS JAMES L | buy | 0 |
| Dec 31, 13 | Shuler Alan | other | 21,457 |
| Nov 30, 13 | Shuler Alan | other | 17,793 |
| Sep 20, 13 | Smith Scott E | other | 100,000 |
| Sep 20, 13 | Smith Scott E | other | 0 |
| Sep 20, 13 | DAVIS JAMES L | buy | 150,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PUMD coverage
Recent articles, reports, and earnings notes.
No research on PUMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PUMD report →